Risankizumab efficacy and safety based on prior inadequate response or intolerance to advanced therapy: post hoc analysis of the INSPIRE and COMMAND phase 3 studies
基于既往对高级疗法反应不足或不耐受的Risankizumab疗效和安全性：INSPIRE和COMMAND 3期研究的事后分析
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf005
Panaccione, Remo; Louis, Edouard; Colombel, Jean-Frederic; D'Haens, Geert; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Takeuchi, Ken; Rubin, David T; Kalabic, Jasmina; Chien, Karen B; Chen, Su; Cheng, Ling; Zhang, Yafei; Duan, W Rachel; Vladea, Ramona; Hecht, Patrick M; Morisset, Pierre; Schreiber, Stefan; Ferrante, Marc
